These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33652387)

  • 1. Conducting Non-COVID-19 Clinical Trials during the Pandemic: Can Today's Learning Impact Framework Efficiency?
    Lalova T; Negrouk A; Deleersnijder A; Valcke P; Huys I
    Eur J Health Law; 2020 Oct; 27(5):425-450. PubMed ID: 33652387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical review of patient safety and public health in EU clinical trials legislation: impact of COVID-19 pandemic.
    Olimid AP; Olimid DA
    Rom J Morphol Embryol; 2020; 61(1):277-281. PubMed ID: 32747923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union.
    de Jong AJ; Santa-Ana-Tellez Y; van Thiel GJMW; Zuidgeest MGP; Siiskonen SJ; Mistry D; de Boer A; Gardarsdottir H;
    Clin Pharmacol Ther; 2021 Jun; 109(6):1517-1527. PubMed ID: 33666223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.
    Vissers MFJM; Cohen AF; Van Gerven JMA; Groeneveld GJ
    Br J Clin Pharmacol; 2021 Mar; 87(3):837-844. PubMed ID: 32668047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporary derogation from European environmental legislation for clinical trials of genetically modified organisms for coronavirus disease 2019.
    Iglesias-Lopez C
    Cytotherapy; 2021 Jan; 23(1):10-11. PubMed ID: 33082093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
    ; Diallo A; Trøseid M; Simensen VC; Boston A; Demotes J; Olsen IC; Chung F; Paiva JA; Hites M; Ader F; Arribas JR; Baratt-Due A; Melien Ø; Tacconelli E; Staub T; Greil R; Tsiodras S; Briel M; Esperou H; Mentré F; Eustace J; Saillard J; Delmas C; LeMestre S; Dumousseaux M; Costagliola D; Røttingen JA; Yazdanpanah Y
    Clin Microbiol Infect; 2022 Jan; 28(1):1-5. PubMed ID: 34763056
    [No Abstract]   [Full Text] [Related]  

  • 9. [More stringent requirements concerning clinical research. The new EU rules come into effect on May 1].
    Lafolie P
    Lakartidningen; 2004 Mar; 101(10):917-20. PubMed ID: 15055055
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials during COVID-19.
    Singh AG; Chaturvedi P
    Head Neck; 2020 Jul; 42(7):1516-1518. PubMed ID: 32348582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Ethics and Research.
    Meagher KM; Cummins NW; Bharucha AE; Badley AD; Chlan LL; Wright RS
    Mayo Clin Proc; 2020 Jun; 95(6):1119-1123. PubMed ID: 32402511
    [No Abstract]   [Full Text] [Related]  

  • 12. An ethics framework for consolidating and prioritizing COVID-19 clinical trials.
    Meyer MN; Gelinas L; Bierer BE; Hull SC; Joffe S; Magnus D; Mohapatra S; Sharp RR; Spector-Bagdady K; Sugarman J; Wilfond BS; Lynch HF
    Clin Trials; 2021 Apr; 18(2):226-233. PubMed ID: 33530721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials for COVID-19 should include sex as a variable.
    Bischof E; Wolfe J; Klein SL
    J Clin Invest; 2020 Jul; 130(7):3350-3352. PubMed ID: 32392184
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on clinical trials with drugs.
    Hasford J
    Expert Opin Drug Saf; 2020 Nov; 19(11):1373-1375. PubMed ID: 32970481
    [No Abstract]   [Full Text] [Related]  

  • 15. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
    Tan AC; Ashley DM; Khasraw M
    Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completion of clinical trials in light of COVID-19.
    Burki TK
    Lancet Respir Med; 2020 Dec; 8(12):1178-1180. PubMed ID: 33010809
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Union. Ethical considerations for clinical trials on medicinal products conducted with the paediatric population.
    Eur J Health Law; 2008 Jul; 15(2):223-50. PubMed ID: 18988606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The architecture of the European Union's pandemic preparedness and response policy framework.
    Eerens D; Hrzic R; Clemens T
    Eur J Public Health; 2023 Feb; 33(1):42-48. PubMed ID: 36399053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the First Wave of COVID-19 on Physical Activity Promotion in the European Union: Results From a Policymaker Survey.
    Gelius P; Tcymbal A; Whiting S; Messing S; Abu-Omar K; Geidl W; Reimers AK; Pfeifer K; Mendes R; Berdzuli N; Breda J
    J Phys Act Health; 2021 Oct; 18(12):1490-1494. PubMed ID: 34702788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.